Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-012539

EVP, Chief R&D Officer sold 6,326 shares at $60.38 ($381,937)

From the SEC's structured data for this filing

Trades in this filing

Friberg Gregory R · EVP, Chief R&D Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-26 Sale : show line 1 in the form −6,326 $60.38 $381,937 37,578 D
Open-market sales · 6,326 sh · avg $60.38 · $381,937
Loading xslF345X05/wk-form4_1772156343.xml…